Premium
Enalapril‐induced anemia in a renal transplant patient
Author(s) -
ÖZBEK NAMIK,
ÖZEN SEZA,
SAATĈI üMIT
Publication year - 1997
Publication title -
pediatrics international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.49
H-Index - 63
eISSN - 1442-200X
pISSN - 1328-8067
DOI - 10.1111/j.1442-200x.1997.tb03654.x
Subject(s) - reticulocytosis , medicine , enalapril , anemia , macrocytosis , hematocrit , hemoglobin , gastroenterology , urology , angiotensin converting enzyme , blood pressure
Side‐effects of angiotensin converting enyzme (ACE) inhibitors, such as a slight decrease in hematocrit, are increasingly being reported. A 14‐year‐old renal transplant patient on enalapril therapy developed anemia with reticulocytosis. She was investigated for other causes of anemia and enalapril therapy was ceased. Her hemoglobin level increased and reticulocyte count decreased after cessation of therapy. No other cause of anemia was found. Although anemia in patients receiving ACE inhibitors such as enalapril has previously been reported, this is the first reported patient who developed anemia associated with mild reticulocytosis and macrocytosis.